Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa‐carbidopa intrajejunal gel

13 Nov 2020

Abstract excerpt

BACKGROUND AND PURPOSE: Recent data suggest that imbalances in the composition of the gut microbiota (GM) could exacerbate the progression of Parkinson disease (PD). The effects of levodopa (LD) have been poorly assessed, and those of LD-carbidopa intestinal gel (LCIG) have not been evaluated so far. The aim of this study was to identify the effect of LD and LCIG, in particular, on the GM and metabolome. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to Gut microbiota and health
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33185912
DOI: 10.1111/ene.14644

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut microbiota and metabolome distinctive features in Parkinson disease: Focus on levodopa and levodopa‐carbidopa intrajejunal gelPMID 33185912Read ↗

A review of studies on gut microbiota and levodopa metabolismSemantic proximity Read ↗

Clinical Phenotypes of Parkinson's Disease Associate with Distinct Gut Microbiota and Metabolome Enterotypes.Semantic proximity Read ↗

Associations Between Gut Microbiota Composition and Impulse Control Disorders in Parkinson’s DiseaseSemantic proximity Read ↗

Microbial Diversity in Drug Naïve Parkinson’s Disease PatientsSemantic proximity Read ↗

Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain AxisSemantic proximity Read ↗

Dopaminergic Medication Accentuates Fecal Gut Microbiome Changes in Parkinson’s DiseaseSemantic proximity Read ↗

Alterations of gut microbiota and metabolome with Parkinson's diseaseSemantic proximity Read ↗

Analysis of Gut Microbiota in Patients with Parkinson’s DiseaseSemantic proximity Read ↗

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patientsSemantic proximity Read ↗

Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical featuresSemantic proximity Read ↗

Role of the Microbiota-Metabolite Axis in the Rotenone Model of Early-Stage Parkinson's DiseaseSemantic proximity Read ↗

Comparison study of gut microbiota in case of Parkinson’s disease and other neurological disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.